➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Colorcon
Harvard Business School
Baxter
AstraZeneca

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: glecaprevir; pibrentasvir


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

glecaprevir; pibrentasvir

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. 0074-2625-01 1 DOSE PACK in 1 CARTON (0074-2625-01) > 3 TABLET, FILM COATED in 1 DOSE PACK
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. 0074-2625-28 4 CARTON in 1 CARTON (0074-2625-28) > 7 DOSE PACK in 1 CARTON > 3 TABLET, FILM COATED in 1 DOSE PACK
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. 0074-2625-56 2 CARTON in 1 CARTON (0074-2625-56) > 4 CARTON in 1 CARTON > 7 DOSE PACK in 1 CARTON > 3 TABLET, FILM COATED in 1 DOSE PACK
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Mallinckrodt
Colorcon
Boehringer Ingelheim
Merck